262P Pragmatic clinical trial assessing response to neoadjuvant taxotere and trastuzumab in Nigerian women with HER2-positive breast cancer (ARETTA): First report from the Nigerian breast cancer study group
2023Annals of OncologyJournalOpen access
10.1016/j.annonc.2023.09.459Full text0 citations